Sort by
Keyphrases
Clinical Trials
100%
Parkinson's Disease
100%
Early Disease
100%
Disease-related
100%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
100%
Healthy Controls
40%
Motor Symptoms
20%
Parkinson Patients
20%
Unified Parkinson's Disease Rating Scale (UPDRS)
20%
Hoehn-Yahr Stage
20%
Disease Stage
10%
Cerebellum
10%
Therapeutic Intervention
10%
Gyrus
10%
Disease Diagnosis
10%
Treatment Effect
10%
Symptom Assessment
10%
Therapeutic Effect
10%
Positron Emission Tomography
10%
Disease Biomarker
10%
Glucose Metabolism
10%
Paracentral
10%
Whole Brain
10%
Disease-modifying Therapy
10%
Pons
10%
Symptom Score
10%
Machine Learning Approach
10%
Occipital Region
10%
Prefrontal Regions
10%
Hypometabolism
10%
Early Parkinson's Disease
10%
Metabolic Pattern
10%
Parieto-occipital
10%
Highly Similar
10%
Control Disease
10%
Sensitive Biomarker
10%
Disease Complexity
10%
Canonical Variate Analysis
10%
Hypermetabolism
10%
Lentiform nucleus
10%
Parkinson's Disease Progression
10%
Two-machine
10%
Scaled Subprofile Model
10%
Multivariate Classification
10%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
100%
Positron Emission Tomography
100%
Glucose Metabolism
33%
Hypermetabolism
33%
Neuroscience
Parkinson's Disease
100%
Positron Emission Tomography
100%
Positron Emission Tomography
21%
Cerebellum
7%
Thalamus
7%
Gyri
7%
Metabolic Pathway
7%
Pons
7%
Lentiform Nucleus
7%